Skip to main content

Table 1 Demographic characteristics of the UHH cohort (n = 82)

From: Pirfenidone improves survival in IPF: results from a real-life study

Age 74.9 ± 11a
 Never smokers 29 (35.3%)
 Smokers 53 (64.7%)
Pack Years 43.5 ± 32.1a
Radiological pattern (Definite UIP/Possible UIP) 47(57.3%)/35(42.7%)
Advanced disease (DLco< 30%) 7(8.5%)
Surgical lung biopsy 13 (15.9%)
FEV1% 87.4 ± 22.7a
FVC % 81.5 ± 19.5a
DLco % 54.4 ± 17.9a
Median follow-up time (IQR) 17.4 months (9.5–30.9).
Deaths 15 (18.3%)
  1. UIP usual interstitial pneumonia, FEV1 forced expiratory volume in 1 s, FVC forced vital capacity, DLco diffusing capacity of the lung for carbon monoxide
  2. aThe values are expressed as mean ± SD